E.2 - PPI MEDIC Questions Response Amendment 1.xlsx
Posted: April 15, 2026
• Type: .xlsx
• Size: 0.03MB
Opportunity Assistant
Loading
Overview
Related Opportunity
Related Agency
Summary
This Q&A response relates to a solicitation for the PPI MEDIC contract, specifically addressing various inquiries from potential offerors regarding the technical proposal instructions, evaluation factors, and requirements for submission.
The responses clarify several key aspects of the solicitation process, including:
- Page limits for technical proposals
- Requirements for cover letters and acronyms
- Implications of the Inflation Reduction Act on proposed methodologies
Notably, CMS has confirmed that cover letters will not count towards page limits, while separate lists of acronyms are not permitted. Additionally, CMS has maintained the original page limit for technical approaches and will not provide baseline payment years or share incumbent audit methodologies.
The document also addresses eligibility requirements for offerors under the Women-Owned Small Business (WOSB) Program Set-Aside, confirming that active WOSB certification is mandatory at multiple stages: proposal submission and award.
Furthermore, it clarifies that offerors must propose their own Level of Effort (LOE) for each Contract Line Item Number (CLIN), as these values will be finalized upon award based on successful proposals. The responses emphasize that all offerors may participate in Phase 2 regardless of their Phase 1 advisory notifications but highlight that only those with high ratings in Factor 1 will be encouraged to proceed.
Moreover, the document outlines expectations regarding organizational conflict of interest (OCI) considerations and confirms that mitigations will be evaluated on a case-by-case basis. It specifies that contractors providing services to Medicare Advantage Organizations (MAOs) or Part D plan sponsors may face OCI issues if they are involved in oversight activities.
Lastly, it provides insights into workload assumptions for audits and clarifies expectations regarding data access during contractor transitions. This Q&A document serves as a critical resource for potential bidders to navigate the complexities of the solicitation effectively.
The responses clarify several key aspects of the solicitation process, including:
- Page limits for technical proposals
- Requirements for cover letters and acronyms
- Implications of the Inflation Reduction Act on proposed methodologies
Notably, CMS has confirmed that cover letters will not count towards page limits, while separate lists of acronyms are not permitted. Additionally, CMS has maintained the original page limit for technical approaches and will not provide baseline payment years or share incumbent audit methodologies.
The document also addresses eligibility requirements for offerors under the Women-Owned Small Business (WOSB) Program Set-Aside, confirming that active WOSB certification is mandatory at multiple stages: proposal submission and award.
Furthermore, it clarifies that offerors must propose their own Level of Effort (LOE) for each Contract Line Item Number (CLIN), as these values will be finalized upon award based on successful proposals. The responses emphasize that all offerors may participate in Phase 2 regardless of their Phase 1 advisory notifications but highlight that only those with high ratings in Factor 1 will be encouraged to proceed.
Moreover, the document outlines expectations regarding organizational conflict of interest (OCI) considerations and confirms that mitigations will be evaluated on a case-by-case basis. It specifies that contractors providing services to Medicare Advantage Organizations (MAOs) or Part D plan sponsors may face OCI issues if they are involved in oversight activities.
Lastly, it provides insights into workload assumptions for audits and clarifies expectations regarding data access during contractor transitions. This Q&A document serves as a critical resource for potential bidders to navigate the complexities of the solicitation effectively.
Show All